The Effect of Digestion and Drug Load on Halofantrine Absorption from Self-nanoemulsifying Drug Delivery System (SNEDDS)
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
A super-saturated self-nanoemulsifying drug delivery system (super-SNEDDS), containing the poorly water-soluble drug halofantrine (Hf) at 150% of equilibrium solubility (S eq), was compared in vitro and in vivo with a conventional SNEDDS (75% of S eq) with respect to bioavailability and digestibility. Further, the effect of digestion on oral absorption of Hf from SNEDDS and super-SNEDDS was assessed by incorporation of the lipase inhibitor tetrahydrolipstatin (orlistat) into the SNEDDS. The SNEDDS contained soybean oil/Maisine 34-I (1:1), Kolliphor RH40, and ethanol at a ratio of 55:35:10, w/w percent. For the dynamic in vitro lipolysis, the precipitation of Hf at 60 min was significantly larger for the super-SNEDDS (66.8 ± 16.4%) than for the SNEDDS (18.5 ± 9.2%). The inhibition of the in vitro digestion by orlistat (1% (w/w)) lowered drug precipitation significantly for both the super-SNEDDS (36.8 ± 1.7%) and the SNEDDS (3.9 ± 0.7%). In the in vivo studies, the super-SNEDDS concept proved valid in a rat model with a significantly larger C max for the super-SNEDDS (964 ± 167 ng/mL) than for the SNEDDS (506 ± 112 ng/mL). The bioavailability of Hf dosed in super-SNEDDS (32.9 ± 3.6%) and SNEDDS (22.5 ± 6.3%) did not change significantly with co-administration of orlistat (45.5 ± 7.3% and 21.9 ± 6.5%, respectively). However, the pharmacokinetic parameters changed; the t max of the super-SNEDDS (1.3 ± 0.1 h) and SNEDDS (2.8 ± 1.2 h) were significantly lower when dosed with orlistat (6.0 ± 1.3 and 6.3 ± 1.2 h, respectively). These findings suggest that the role of lipid digestion for the absorption of drugs from SNEDDS may be less important than previously thought.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To-date the merits of LBDDS have been limited to a relatively small number of highly lipophilic drugs, and a key drawback is that the dose of drug that can be loaded in LBDDS is hindered by the drug solubility in lipids (Thomas et al., 2012; Michaelsen et al., 2016).”
From Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across PermeapadⓇ membrane and in vivo absorption (2020) · cites this paper as Michaelsen et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, the majority of studies reported in the literature comparing non-supersaturated and supersaturated LBDDS have used the same drug dose, which resulted in administration of less lipid volume in the case of sLBDDS (Siqueira et al., 2017; Michaelsen et al., 2016; Thomas et al., 2014).”
From Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across PermeapadⓇ membrane and in vivo absorption (2020) · cites this paper as Michaelsen et al., 2016
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Supersaturated lipid-based drug delivery systems have recently been investigated for oral administration for a variety of lipophilic drugs and have shown either equivalent or superior oral bioavailability compared to conventional non-supersaturated lipid-based drug delivery systems.”
From Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across PermeapadⓇ membrane and in vivo absorption (2020) · cites this paper as Michaelsen et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430 · cited 1×
“The physico-chemical properties of highly lipophilic compounds often result in poor and variable bioavailability (1,2).”
Lipid-based vehicles for the oral delivery of poorly water soluble drugs
Humberstone, A. J., & Charman, W. N. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00494-2 · Cited by 577 · cited 1×
“The delivery of lipophilic drugs in SNEDDS often results in an increased oral absorption and hence an improved bioavailability (3).”
When poor solubility becomes an issue: From early stage to proof of concept
Stegemann, S., Leveiller, F., Franchi, D., de Jong, H., & Lindén, H. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.05.110 · Cited by 567 · cited 1×
“The physico-chemical properties of highly lipophilic compounds often result in poor and variable bioavailability (1,2).”
Hofmann, A. F., & Borgström, B. (1964) · Journal of Clinical Investigation · doi:10.1172/jci104909 · Cited by 443 · cited 1×
“and the physico-chemical behavior of the digestion products have been extensively studied since the early 1960s (10).”
Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin
Hadváry, P., Lengsfeld, H., & Wolfer, H. (1988) · Biochemical Journal · doi:10.1042/bj2560357 · Cited by 345 · cited 1×
“However, it is also possible that the in vivo lipase activity is not fully inhibited by the amount of orlistat dosed; orlistat is inhibiting the pancreatic lipase at a stoichiometry of around 1:1 (31).”
WEIBEL, E. K., HADVARY, P., HOCHULI, E., KUPFER, E., & LENGSFELD, H. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.1081 · Cited by 341 · cited 2×
“In vitro studies with orlistat have shown that when it interacts with porcine pancreatic lipase, the interaction is irreversible; however, the same may not be true for all lipases (14).”
A dynamic in vitro lipolysis model
Zangenberg, N. H., Müllertz, A., Kristensen, H. G., & Hovgaard, L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00169-5 · Cited by 287
Self-citationInfluence of lipolysis on drug absorption from the gastro-intestinal tract
MacGregor, K. J., Embleton, J. K., Lacy, J. E., Perry, E. A., Solomon, L. J., Seager, H., & Pouton, C. W. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00489-9 · Cited by 221 · cited 1×
“structures and mixed micelles, which will facilitate transport of the drug to the epithelial membrane (30).”
Thomas, N., Holm, R., Müllertz, A., & Rades, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.027 · Cited by 215
Self-citationDahan, A., & Hoffman, A. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9054-x · Cited by 195 · cited 1×
“In vitro lipolysis is often used to assess lipid formulations such as SNEDDS (28).”
Cited by
50 years of oral lipid-based formulations: provenance, progress and future perspectives
Feeney, O. M., Crum, M. F., McEvoy, C. L., Trevaskis, N. L., Williams, H. D., Pouton, C. W., Charman, W. N., Bergström, C. A. S., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.007 · Cited by 426
An update on oral drug delivery via intestinal lymphatic transport
Zhang, Z., Lu, Y., Qi, J., & Wu, W. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.12.022 · Cited by 231
Vinarov, Z., Abrahamsson, B., Artursson, P., Batchelor, H. K., Berben, P., Bernkop‐Schnürch, A., Butler, J., Ceulemans, J., Davies, N. M., Dupont, D., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.001 · Cited by 168
Self-citationResponsive self-assembled nanostructured lipid systems for drug delivery and diagnostics
Fong, W., Negrini, R., Vallooran, J. J., Mezzenga, R., & Boyd, B. J. (2016) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2016.08.077 · Cited by 158
Analysis of 3D Prints by X-ray Computed Microtomography and Terahertz Pulsed Imaging
Markl, D., Zeitler, J. A., Rasch, C., Michaelsen, M. H., Müllertz, A., Rantanen, J., Rades, T., & Bøtker, J. (2017) · Pharmaceutical Research · doi:10.1007/s11095-016-2083-1 · Cited by 96
“Drug release was experimentally determined by in-vitro release testing using the basket method (USP 1) in HCl pH 1 on a Erweka DT 70 (Heusanstamm, Germany) at 100 rpm and 37C and high-performance liquid chromatography (HPLC) analysis was carried out on a UHPLC+ Dionex Ultimate 3000 Thermo Fischer Scientific (Waltham,…”
MethodSelf-citation
Metadata
- Authors
- Michaelsen, M. H., Wasan, K. M., Sivak, O., Müllertz, A., & Rades, T.
- Affiliations
- University of Copenhagen (DK)
- University of British Columbia (CA)
- Corresponding author
- Müllertz, Anette
- Venue
- The AAPS Journal
- Published
- 2015-10-20
- Volume
- 18
- Issue
- 1
- Pages
- 180-186
- ISSN
- 1550-7416 (ISSN-L)
- PMC
- PMC4706280
- OpenAlex
- W2177886515
- Cited by
- 55
- References
- 32
- Citations by year
- 2025: 9 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 8 · 2020: 9 · 2019: 6 · 2018: 6 · 2017: 3 · 2016: 4
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- The AAPS Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Agricultural and Biological Sciences › Food Science › Proteins in Food Systems
- Keywords
- halofantrine, self-nanoemulsifying drug delivery system, oral bioavailability, drug absorption, lipid digestion, orlistat, lipase inhibition, in vitro lipolysis, drug precipitation, poorly water-soluble drugs, pharmacokinetics
- MeSH terms
- Orlistat, Animals, Antimalarials, Biological Availability, Chemistry, Pharmaceutical, Drug Interactions, Emulsions, Enzyme Inhibitors, Excipients, Intestinal Absorption, Lactones, Lipolysis, Male, Phenanthrenes, Solubility, Drug Delivery Systems, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effect of Digestion and Drug Load on Halofantrine Absorption from Self-nanoemulsifying Drug Delivery System (SNEDDS). https://app.cochat.ai/papers/10.1208/s12248-015-9832-7
- The paper
- Michaelsen, M. H., Wasan, K. M., Sivak, O., Müllertz, A., & Rades, T. (2016). The Effect of Digestion and Drug Load on Halofantrine Absorption from Self-nanoemulsifying Drug Delivery System (SNEDDS). The AAPS Journal. https://doi.org/10.1208/s12248-015-9832-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.